Schedule 13D ownership disclosure

TOURMALINE BIO INC

Security class unavailable · CUSIP: 89157D105

Event date: 2023-10-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
183,177
Percent of class
0.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-112580
Form type
SC 13D/A
Filer
Qiming U.S. Healthcare GP II, LLC
CIK
CIK 1868862
Filed
Oct 30, 2023
Reporting period
Oct 19, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub